8 results about "Baeckea" patented technology

The invention provides a compound traditional Chinese medicine antipruritic composition and camellia oil containing the same. The compound traditional Chinese medicine antipruritic composition is prepared from the following traditional Chinese medicine raw materials in parts by weight: 0.1-25 parts of baeckea frutescens, 0.2-30 parts of perfoliote knotweed herb, 0.5-30 parts of eriocarpous glochidion herb, 1-35 parts of purslane herb, 0.1-25 parts of sweet wormwood herb, 0.1-25 parts of mosla dianthera, 1-25 parts of xanthium sibiricum and 0.1-5 parts of duckweed. The antipruritic composition is prepared by extracting traditional Chinese medicines, is safe in components and has a relatively good antipruritic effect, and when the antipruritic composition is further added into the camellia oil, the antipruritic composition is mild and non-irritant to skin and has very good antipruritic activity.

The application belongs to the technical field of biotechnology, and particularly relates to a pharmaceutical composition containing exosomes and application thereof. The pharmaceutical composition containing exosomes comprises stem cell exosomes, recombinant IGFBP7 protein and baeckea fruitin B; the amino acid sequence of the recombinant IGFBP7 protein is shown as SEQ ID NO:1. Test results show that the combination of umbilical cord mesenchymal stem cell exosomes, baeckea fruitin B and recombinant IGFBP7 protein can stimulate hair follicle stem cells, prolong the initial stage of hair growth of hair follicles, and thus effectively improve the hair loss of patients.

The invention relates to a traditional Chinese medicine composition for promoting neurosurgery postoperative rehabilitation and application thereof, and relates to the technical field of traditional Chinese medicine, the traditional Chinese medicine composition for promoting neurosurgery postoperative rehabilitation comprises the following raw materials by weight: 25-35 parts of dracocephalum heterophyllum, 10-20 parts of baeckea frutescens, 10-20 parts of cymbaria, 8-15 parts of humulus lupulus, 5-10 parts of lotus corniculatus, and 2-5 parts of licorice. According to the traditional Chinese medicine composition, dracocephalum heterophyllum is taken as a monarch drug, the baeckea frutescens and cymbaria are taken as ministerial drugs, the hops and the lotus corniculatus are taken as adjuvant drugs, and the liquorice is taken as a conductant drug, and all the drugs are combined and have a synergistic effect, so that the pain symptom of a neurosurgery postoperative patient can be remarkably relieved, the rehabilitation of the neurosurgery postoperative patient is promoted, and the traditional Chinese medicine composition has a wide clinical application prospect.

The application discloses a traditional Chinese medicine composition for treating lung cancer and a preparation method thereof. The traditional Chinese medicine composition comprises the following raw medicinal materials in parts by weight: Platycladi seeds 5-8 parts, Aescleris stems 19-22 parts, Persicae Nucis 12-15 parts, Radix Pulsatillae 5-8 parts, Coicis Semen 35-38 parts, Benincasae Semen 12-15 parts, Herba Gnaphalii 12-15 parts, Baeckea frutescens 12-15 parts, Citri Reticulatae Pericarpium 5-8 parts and Fructus Jujubae 5-8 parts. The traditional Chinese medicine composition is developed on the basis of the pathogenesis of phlegm and blood stasis of lung cancer in traditional Chinese medicine, combined with classical prescriptions for treating lung diseases in traditional Chinese medicine and laboratory anti-lung cancer drug screening research, and has the effect of inhibiting lung cancer cell growth and good effect on the treatment of lung cancer. Experiments prove that the traditional Chinese medicine composition significantly inhibits lung cancer cell proliferation in vitro and improves the lung cancer pathological process of lung cancer mice in vivo, and is a great innovation of lung cancer drugs.

The present application relates to the technical field of medicine, provide a kind of rhizoma Corydalis compound granular material and its preparation method and application, to solve the problem of low oral bioavailability and poor stability of rhizoma Corydalis alkaloids.The granular material is composed of rhizoma Corydalis microcapsule granules, chuanqiong extract, baeckea fruit extract microcrystalline cellulose, sodium carboxymethyl starch and magnesium stearate etc.Rhizoma Corydalis alkaloids are coated by forming phospholipid complex with medicinal grade soybean lecithin, which significantly improves the stability and oral bioavailability of alkaloids.The preparation method includes the following steps: raw material pretreatment, mixing, granulation, drying, whole granulation, mixing and packaging.The granule has good application prospect in the preparation of analgesic oral solid preparations.

The invention belongs to the technical field of compound essential oil, and particularly relates to compound essential oil for external application of pudendum. The invention relates to compound essential oil for external application of pudendum. The compound essential oil for external application of pudendum is prepared from the following components: 400 to 800 mL of camellia oil, 80 to 120 mL of sea buckthorn fruit oil, 60 to 120 mL of baeckea frutescens oil, 30 to 70 mL of cypress oil, 40 to 60 mL of eucalyptus oil, 35 to 75 mL of snake oil, 40 to 60 mL of emu oil, 3 to 6 g of borneol and 0.2 to 0.7 mL of agilawood essential oil. The compound essential oil disclosed by the invention has relatively strong bacteriostatic activity, can achieve relatively good anti-inflammatory and bactericidal effects, can achieve the effects of relieving, dredging collaterals, moistening yin, relieving itching and the like, can be used for preventing and treating diseases such as pruritus vulvae, vagina dryness and sexual hypoactivity of women, and prostatic hyperplasia, haemorrhoids and the like of males, and has a relatively good application prospect.

The invention belongs to the technical field of vegetative propagation of seedlings, and particularly relates to a tissue culture subculture rooting and seedling method for baeckea frutescens. The method comprises the following steps: inoculating subculture bottle seedlings of baeckea frutescens into a strong seedling culture medium for culturing to obtain strong seedlings, wherein the formula of the strong seedling culture medium comprises MS, 20-35g / L of sucrose and 5-6g / L of agar; the strong seedlings are inoculated into a rooting culture medium to be cultured to obtain rooted seedlings, and the formula of the rooting culture medium is as follows: 1 / 2MS, 1-3mg / L of IBA, 1-2mg / L of NAA and 25-35g / L of sucrose; the rooted seedlings are transplanted outdoors for seedling hardening, bottle seedlings are planted into a mixed matrix of nutrient soil and yellow subsoil to be cultured, and water is sprayed for moisturizing. After the subculture bottle seedlings of the baeckea frutescens are cultured for 30 days through the strong seedling culture medium, the stems of the baeckea frutescens are increased and thickened, the rooting rate of the obtained strong seedlings reaches 80%-100% after the strong seedlings are cultured for 60 days through the rooting culture medium, the stem length of the tissue culture seedlings is 5 cm or above, the number of adventitious roots is 6 or above, and the average root length is 1.5 cm or above. After outdoor seedling hardening, the transplanting survival rate reaches 90.15% after 30 days of culture.

The application discloses a dihydrochalcone glycoside compound in traditional Chinese medicine bryonia and a preparation method and application thereof. The preparation method is as follows: taking cup-stem bryonia as initial raw material, taking the aboveground part, crushing, extracting at room temperature with 95% ethanol, concentrating the extract to obtain an extract; dispersing the extract in water, sequentially extracting with petroleum ether, ethyl acetate and n-butanol, recovering the solvents to obtain a petroleum ether part, an ethyl acetate part and an n-butanol part; dissolving the ethyl acetate part extract with 10% ethanol, separating by polyamide column chromatography to obtain three parts A, B and C; and separating the B part by polyamide column chromatography with (ethyl acetate: ethanol: glacial acetic acid: water = 10:5:1:1) to obtain compounds 1, 2 and 3, i.e. dihydrochalcone glycoside compounds. The preparation process is simple, the extraction rate is high, and the development and utilization of the traditional Chinese medicine bryonia are facilitated; the compounds have antioxidant, antitumor and antibacterial activities, and can be applied to antioxidant and inhibition of proliferation of hepatoma cells.